B50.9

Plasmodium falciparum malaria, unspecified

Plasmodium falciparum malaria, represented by code B50.9, is the most severe and life-threatening form of malaria caused by the P. falciparum parasite. Transmitted through the bite of infected female Anopheles mosquitoes, this species is distinguished by its ability to infect erythrocytes of all ages and its unique property of sequestration, where infected red blood cells adhere to vascular endothelium in vital organs. B50.9 is utilized clinically when a diagnosis of falciparum malaria is confirmed via microscopy or rapid diagnostic tests, but the documentation does not specify the presence of major complications such as cerebral involvement, pulmonary edema, or renal failure. Despite being labeled as 'unspecified,' falciparum malaria is always considered a medical emergency due to the potential for rapid progression from uncomplicated symptoms to multi-organ failure and death within 24 hours.

Clinical Symptoms

  • Cyclical high-grade fever
  • Rigors and intense shivering
  • Profuse diaphoresis (sweating)
  • Severe headache
  • Generalized myalgia and arthralgia
  • Nausea and projectile vomiting
  • Abdominal pain
  • Splenomegaly (enlarged spleen)
  • Hepatomegaly (enlarged liver)
  • Mild to moderate jaundice
  • Orthostatic hypotension
  • Significant malaise and fatigue
  • Normocytic anemia

Common Causes

  • Infection by the Plasmodium falciparum protozoan parasite
  • Bite of an infected female Anopheles mosquito (primary vector)
  • Blood transfusion from an infected donor (rare)
  • Congenital transmission from mother to fetus
  • Needle-sharing among intravenous drug users
  • Lack of adequate chemoprophylaxis when traveling to endemic regions
  • Living in or visiting Sub-Saharan Africa, Southeast Asia, or Oceania
  • Immunocompromised status or lack of previous exposure (non-immune individuals)

Documentation & Coding Tips

Explicitly state the Plasmodium species identified via laboratory testing to avoid the less specific B54 code.

Example: Patient presents with cyclical fevers and rigors 10 days after returning from Nigeria. Peripheral blood smear confirms Plasmodium falciparum with 1.2 percent parasitemia. Diagnosis: Plasmodium falciparum malaria, uncomplicated. Plan includes Coartem and monitoring for signs of severe disease such as altered mental status or respiratory distress.

Billing Focus: Identify the specific Plasmodium species (falciparum) to support B50.9 over unspecified malaria codes.

Document the presence or absence of specific complications such as cerebral involvement or renal failure to distinguish between B50.0, B50.8, and B50.9.

Example: Diagnosis: Uncomplicated Plasmodium falciparum malaria. Clinical evaluation shows no evidence of cerebral involvement (GCS 15), no acute kidney injury (Creatinine 0.9), and no pulmonary edema. Patient is hemodynamically stable but requires oral antimalarial therapy for confirmed falciparum infection.

Billing Focus: Documentation of 'uncomplicated' or the absence of manifestations supports B50.9; presence of manifestations would shift the code to B50.0 or B50.8.

Record the parasite density or parasitemia percentage as it dictates the intensity of care and level of medical decision making.

Example: Initial thin smear reveals Plasmodium falciparum at 4 percent parasitemia. Patient is stable but requires admission for close monitoring given the threshold for severe disease risk. No evidence of organ dysfunction at this time. Assessment: Plasmodium falciparum malaria, unspecified complications.

Billing Focus: Parasitemia levels support the medical necessity for higher-level E/M services and inpatient status.

Include travel history, including specific regions and dates, to support the clinical suspicion and diagnostic workup.

Example: Patient returned from a 3-week humanitarian mission in South Sudan two weeks ago. Did not take chemoprophylaxis. Presents with jaundice and fever. Lab results: Plasmodium falciparum positive. Assessment: Plasmodium falciparum malaria, unspecified, suspected chloroquine resistance based on regional epidemiology.

Billing Focus: Contextualizes the diagnostic testing (e.g., PCR, smears) as medically necessary based on exposure risk.

State if the malaria is suspected to be drug-resistant based on regional prevalence or treatment failure.

Example: Patient diagnosed with Plasmodium falciparum malaria following travel to Southeast Asia. Due to known high rates of multidrug-resistant P. falciparum in the region, patient started on Malarone rather than chloroquine. Assessment: Uncomplicated Plasmodium falciparum malaria.

Billing Focus: Supports the selection of more expensive or complex pharmacotherapy regimens.

Relevant CPT Codes

Related Diagnoses

Hierarchy